SIOP is pleased to welcome Dr. Roula Farah (Lebanon) as SIOP Asia SPAWG Chair. Her term runs from October 2026 to October 2029.

Dr Roula Farah is a Professor of General Pediatrics and Pediatric Hematology/Oncology at the Lebanese American University (LAU) Gilbert and Rose-Mary Chagoury School of Medicine and LAU Medical Center–Rizk Hospital in Beirut, Lebanon. She is the recipient in 2026 of the prestigious Fulbright Scholar Award and is currently working for 3 months on Familial Cancer Genes and Cancer Predisposition at Harvard University in Boston at the Dana-Farber Cancer Institute.

She is the Founder and President of CHANCE Association (Lebanon) and CHANCE International (Geneva), major organizations that have impacted the lives and treatment of many children with cancer and blood disorders.

She is Board Certified in Pediatrics and Pediatric Hematology/Oncology (American Board) and Belgian Board (NARIC) and is a Fellow of the American Academy of Pediatrics. She holds a Global Master of Public Health from the Imperial College London, UK and is a professor of Public Health at La Sagesse University, and a Consultant and Coordinator of Pediatric Services at the Fondation Pierre-Fabre project on women and children in Lebanon. Dr Farah is the first International Society of Pediatric Oncology (SIOP) Ambassador to Lebanon, Childhood Cancer International (CCI) Asia Board Member and a Founding member of the Lebanese Palliative Care Society.

She is the representative of Childhood Cancer International (CCI) and Co-Focal Point for the Eastern Mediterranean region towards the World Health Organization regarding the Global Initiative for Childhood Cancer. She is a local, regional and international leader in the field and has several impactful publications in international journals. She is a dedicated patient advocate, speaker, lecturer, researcher and public figure. She received several community and scientific awards throughout her carrier, the most recent ones being the Community Woman Leaders Award in 2025 for her childhood cancer advocacy impact and the Fulbright Visiting Scholar Award in 2026 to Harvard.

Please join us in welcoming Roula to the role.